Ian Cook, M.D., was named chief medical officer and senior vice president of NeuroSigma, Inc., a life-sciences company developing bioelectrical neuromodulation treatments for epilepsy, depression, PTSD, ADHD, and traumatic brain injury. He previously served as a consultant to the company for several years.
Since 1996, Dr. Cook has been a member of the University of California-Los Angeles faculty in various capacities. He continues to hold his academic appointments as a professor of bioengineering at the Henry Samueli School of Engineering and Applied Sciences and of psychiatry and biobehavioral sciences at the David Geffen School of Medicine.
Cook received a BSE in electrical engineering and computer science from Princeton in 1982 and his M.D. from Yale University.